Ketamine for treatment-resistant major depressive disorder: Double-blind active-controlled crossover study.

Paul GlueShona NeehoffBen BeagleholeShabah ShadliNeil McNaughtonNatalie J Hughes-Medlicott

Published in: Journal of psychopharmacology (Oxford, England) (2024)

Our findings add to the literature confirming ketamine's activity against depressive and anxiety symptoms in patients with TRD.

Keyphrases